A  ||| S:0 E:2 ||| DT
third  ||| S:2 E:8 ||| JJ
glucose  ||| S:8 E:16 ||| FW
uptake  ||| S:16 E:23 ||| FW
bypass  ||| S:23 E:30 ||| FW
in  ||| S:30 E:33 ||| FW
Corynebacterium  ||| S:33 E:49 ||| FW
glutamicum  ||| S:49 E:60 ||| FW
ATCC  ||| S:60 E:65 ||| NNP
31833  ||| S:65 E:71 ||| CD
In  ||| S:71 E:74 ||| IN
Corynebacterium  ||| S:74 E:90 ||| NNP
glutamicum ||| S:90 E:100 ||| NN
,  ||| S:100 E:102 ||| ,
the  ||| S:102 E:106 ||| DT
phosphoenolpyruvate-dependent  ||| S:106 E:136 ||| JJ
sugar  ||| S:136 E:142 ||| NN
phosphotransferase  ||| S:142 E:161 ||| NN
system  ||| S:161 E:168 ||| NN
( ||| S:168 E:169 ||| -LRB-
PTS ||| S:169 E:172 ||| NNP
)  ||| S:172 E:174 ||| -RRB-
has  ||| S:174 E:178 ||| VBZ
long  ||| S:178 E:183 ||| RB
been  ||| S:183 E:188 ||| VBN
the  ||| S:188 E:192 ||| DT
only  ||| S:192 E:197 ||| RB
known  ||| S:197 E:203 ||| VBN
glucose  ||| S:203 E:211 ||| JJ
uptake  ||| S:211 E:218 ||| JJ
system ||| S:218 E:224 ||| NN
,  ||| S:224 E:226 ||| ,
but  ||| S:226 E:230 ||| CC
we  ||| S:230 E:233 ||| PRP
recently  ||| S:233 E:242 ||| RB
found  ||| S:242 E:248 ||| VBN
suppressor  ||| S:248 E:259 ||| NN
mutants  ||| S:259 E:267 ||| VBZ
emerging  ||| S:267 E:276 ||| VBG
from  ||| S:276 E:281 ||| IN
a  ||| S:281 E:283 ||| DT
PTS-negative  ||| S:283 E:296 ||| JJ
strain  ||| S:296 E:303 ||| NN
of  ||| S:303 E:306 ||| IN
C.  ||| S:306 E:309 ||| NNP
glutamicum  ||| S:309 E:320 ||| VBD
ATCC  ||| S:320 E:325 ||| NNP
31833  ||| S:325 E:331 ||| CD
on  ||| S:331 E:334 ||| IN
glucose  ||| S:334 E:342 ||| JJ
agar  ||| S:342 E:347 ||| JJ
plates ||| S:347 E:353 ||| NN
,  ||| S:353 E:355 ||| ,
and  ||| S:355 E:359 ||| CC
identified  ||| S:359 E:370 ||| VBD
two  ||| S:370 E:374 ||| CD
alternative  ||| S:374 E:386 ||| JJ
potential  ||| S:386 E:396 ||| JJ
glucose  ||| S:396 E:404 ||| JJ
uptake  ||| S:404 E:411 ||| JJ
systems ||| S:411 E:418 ||| NNS
,  ||| S:418 E:420 ||| ,
the  ||| S:420 E:424 ||| DT
myo-inositol  ||| S:424 E:437 ||| JJ
transporters  ||| S:437 E:450 ||| JJ
encoded  ||| S:450 E:458 ||| NN
by  ||| S:458 E:461 ||| IN
iolT1  ||| S:461 E:467 ||| NNP
and  ||| S:467 E:471 ||| CC
iolT2 ||| S:471 E:476 ||| NNP
.  ||| S:476 E:478 ||| .
The  ||| S:478 E:482 ||| DT
expression  ||| S:482 E:493 ||| NN
of  ||| S:493 E:496 ||| IN
either  ||| S:496 E:503 ||| DT
gene  ||| S:503 E:508 ||| NN
renders  ||| S:508 E:516 ||| VBD
the  ||| S:516 E:520 ||| DT
PTS-negative  ||| S:520 E:533 ||| JJ
strain  ||| S:533 E:540 ||| NN
WTΔptsH  ||| S:540 E:548 ||| JJ
capable  ||| S:548 E:556 ||| JJ
of  ||| S:556 E:559 ||| IN
growing  ||| S:559 E:567 ||| VBG
on  ||| S:567 E:570 ||| IN
glucose ||| S:570 E:577 ||| NN
.  ||| S:577 E:579 ||| .
In  ||| S:579 E:582 ||| IN
the  ||| S:582 E:586 ||| DT
present  ||| S:586 E:594 ||| JJ
study ||| S:594 E:599 ||| NN
,  ||| S:599 E:601 ||| ,
we  ||| S:601 E:604 ||| PRP
found  ||| S:604 E:610 ||| VBD
a  ||| S:610 E:612 ||| DT
suppressor  ||| S:612 E:623 ||| NN
strain  ||| S:623 E:630 ||| NN
that  ||| S:630 E:635 ||| WDT
still  ||| S:635 E:641 ||| RB
grew  ||| S:641 E:646 ||| VBD
on  ||| S:646 E:649 ||| IN
glucose  ||| S:649 E:657 ||| VBG
even  ||| S:657 E:662 ||| RB
after  ||| S:662 E:668 ||| IN
the  ||| S:668 E:672 ||| DT
iolT1  ||| S:672 E:678 ||| NNP
and  ||| S:678 E:682 ||| CC
iolT2  ||| S:682 E:688 ||| CD
genes  ||| S:688 E:694 ||| NNS
were  ||| S:694 E:699 ||| VBD
both  ||| S:699 E:704 ||| DT
disrupted  ||| S:704 E:714 ||| VBN
under  ||| S:714 E:720 ||| IN
the  ||| S:720 E:724 ||| DT
PTS-negative  ||| S:724 E:737 ||| JJ
background ||| S:737 E:747 ||| NN
.  ||| S:747 E:749 ||| .
Whole-genome  ||| S:749 E:762 ||| JJ
sequencing  ||| S:762 E:773 ||| NN
of  ||| S:773 E:776 ||| IN
the  ||| S:776 E:780 ||| DT
suppressor  ||| S:780 E:791 ||| NN
strain  ||| S:791 E:798 ||| NN
SPH1  ||| S:798 E:803 ||| VBZ
identified  ||| S:803 E:814 ||| VBN
a  ||| S:814 E:816 ||| DT
G-to-T  ||| S:816 E:823 ||| JJ
exchange  ||| S:823 E:832 ||| NN
at  ||| S:832 E:835 ||| IN
134  ||| S:835 E:839 ||| CD
bp  ||| S:839 E:842 ||| JJ
upstream  ||| S:842 E:851 ||| NN
of  ||| S:851 E:854 ||| IN
the  ||| S:854 E:858 ||| DT
bglF  ||| S:858 E:863 ||| JJ
gene  ||| S:863 E:868 ||| NN
encoding  ||| S:868 E:877 ||| VBD
an  ||| S:877 E:880 ||| DT
EII  ||| S:880 E:884 ||| NNP
component  ||| S:884 E:894 ||| NN
of  ||| S:894 E:897 ||| IN
the  ||| S:897 E:901 ||| DT
β-glucoside-PTS ||| S:901 E:916 ||| JJ
,  ||| S:916 E:918 ||| ,
which  ||| S:918 E:924 ||| WDT
is  ||| S:924 E:927 ||| VBZ
found  ||| S:927 E:933 ||| VBN
in  ||| S:933 E:936 ||| IN
limited  ||| S:936 E:944 ||| JJ
wild-type  ||| S:944 E:954 ||| JJ
strains  ||| S:954 E:962 ||| NNS
of  ||| S:962 E:965 ||| IN
C.  ||| S:965 E:968 ||| NNP
glutamicum ||| S:968 E:978 ||| NN
.  ||| S:978 E:980 ||| .
Introduction  ||| S:980 E:993 ||| NN
of  ||| S:993 E:996 ||| IN
the  ||| S:996 E:1000 ||| DT
mutation  ||| S:1000 E:1009 ||| NN
into  ||| S:1009 E:1014 ||| IN
strain  ||| S:1014 E:1021 ||| NN
WTΔptsH  ||| S:1021 E:1029 ||| NN
allowed  ||| S:1029 E:1037 ||| VBD
the  ||| S:1037 E:1041 ||| DT
PTS-negative  ||| S:1041 E:1054 ||| JJ
strain  ||| S:1054 E:1061 ||| NN
to  ||| S:1061 E:1064 ||| TO
grow  ||| S:1064 E:1069 ||| VB
on  ||| S:1069 E:1072 ||| IN
glucose ||| S:1072 E:1079 ||| NN
.  ||| S:1079 E:1081 ||| .
Reverse  ||| S:1081 E:1089 ||| NNP
transcription-quantitative  ||| S:1089 E:1116 ||| NNP
PCR  ||| S:1116 E:1120 ||| NNP
analysis  ||| S:1120 E:1129 ||| NN
revealed  ||| S:1129 E:1138 ||| VBD
that  ||| S:1138 E:1143 ||| IN
the  ||| S:1143 E:1147 ||| DT
mutation  ||| S:1147 E:1156 ||| NN
upregulates  ||| S:1156 E:1168 ||| VBD
the  ||| S:1168 E:1172 ||| DT
bglF  ||| S:1172 E:1177 ||| JJ
gene  ||| S:1177 E:1182 ||| NN
by  ||| S:1182 E:1185 ||| IN
approximately  ||| S:1185 E:1199 ||| RB
11-fold ||| S:1199 E:1206 ||| CD
.  ||| S:1206 E:1208 ||| .
Overexpression  ||| S:1208 E:1223 ||| NNP
of  ||| S:1223 E:1226 ||| IN
bglF  ||| S:1226 E:1231 ||| JJ
under  ||| S:1231 E:1237 ||| IN
the  ||| S:1237 E:1241 ||| DT
gapA  ||| S:1241 E:1246 ||| JJ
promoter  ||| S:1246 E:1255 ||| NN
in  ||| S:1255 E:1258 ||| IN
strain  ||| S:1258 E:1265 ||| NN
WTΔptsH  ||| S:1265 E:1273 ||| NN
rendered  ||| S:1273 E:1282 ||| VBD
the  ||| S:1282 E:1286 ||| DT
strain  ||| S:1286 E:1293 ||| NN
capable  ||| S:1293 E:1301 ||| NN
of  ||| S:1301 E:1304 ||| IN
growing  ||| S:1304 E:1312 ||| VBG
on  ||| S:1312 E:1315 ||| IN
glucose ||| S:1315 E:1322 ||| NN
,  ||| S:1322 E:1324 ||| ,
and  ||| S:1324 E:1328 ||| CC
deletion  ||| S:1328 E:1337 ||| NN
of  ||| S:1337 E:1340 ||| IN
bglF  ||| S:1340 E:1345 ||| JJ
in  ||| S:1345 E:1348 ||| IN
strain  ||| S:1348 E:1355 ||| NN
SPH1  ||| S:1355 E:1360 ||| VBZ
abolished  ||| S:1360 E:1370 ||| VBN
the  ||| S:1370 E:1374 ||| DT
growth  ||| S:1374 E:1381 ||| NN
again ||| S:1381 E:1386 ||| RB
,  ||| S:1386 E:1388 ||| ,
proving  ||| S:1388 E:1396 ||| VBG
that  ||| S:1396 E:1401 ||| IN
bglF  ||| S:1401 E:1406 ||| NNP
is  ||| S:1406 E:1409 ||| VBZ
responsible  ||| S:1409 E:1421 ||| JJ
for  ||| S:1421 E:1425 ||| IN
glucose  ||| S:1425 E:1433 ||| JJ
uptake  ||| S:1433 E:1440 ||| NN
in  ||| S:1440 E:1443 ||| IN
the  ||| S:1443 E:1447 ||| DT
suppressor  ||| S:1447 E:1458 ||| NN
strain ||| S:1458 E:1464 ||| NN
.  ||| S:1464 E:1466 ||| .
Simultaneous  ||| S:1466 E:1479 ||| JJ
disruption  ||| S:1479 E:1490 ||| NN
of  ||| S:1490 E:1493 ||| IN
three  ||| S:1493 E:1499 ||| CD
glucokinase  ||| S:1499 E:1511 ||| CD
genes ||| S:1511 E:1516 ||| NNS
,  ||| S:1516 E:1518 ||| ,
glk  ||| S:1518 E:1522 ||| NNS
( ||| S:1522 E:1523 ||| -LRB-
Cgl2185 ||| S:1523 E:1530 ||| NNP
,  ||| S:1530 E:1532 ||| ,
NCgl2105 ||| S:1532 E:1540 ||| CD
) ||| S:1540 E:1541 ||| -RRB-
,  ||| S:1541 E:1543 ||| ,
ppgK  ||| S:1543 E:1548 ||| NNP
( ||| S:1548 E:1549 ||| -LRB-
Cgl1910 ||| S:1549 E:1556 ||| NNP
,  ||| S:1556 E:1558 ||| ,
NCgl1835 ||| S:1558 E:1566 ||| CD
) ||| S:1566 E:1567 ||| -RRB-
,  ||| S:1567 E:1569 ||| ,
and  ||| S:1569 E:1573 ||| CC
Cgl2647  ||| S:1573 E:1581 ||| NNP
( ||| S:1581 E:1582 ||| -LRB-
NCgl2558 ||| S:1582 E:1590 ||| NNP
) ||| S:1590 E:1591 ||| -RRB-
,  ||| S:1591 E:1593 ||| ,
in  ||| S:1593 E:1596 ||| IN
strain  ||| S:1596 E:1603 ||| NN
SPH1  ||| S:1603 E:1608 ||| VBZ
resulted  ||| S:1608 E:1617 ||| VBN
in  ||| S:1617 E:1620 ||| IN
no  ||| S:1620 E:1623 ||| DT
growth  ||| S:1623 E:1630 ||| NN
on  ||| S:1630 E:1633 ||| IN
glucose ||| S:1633 E:1640 ||| NN
.  ||| S:1640 E:1642 ||| .
Plasmid-mediated  ||| S:1642 E:1659 ||| JJ
expression  ||| S:1659 E:1670 ||| NN
of  ||| S:1670 E:1673 ||| IN
any  ||| S:1673 E:1677 ||| DT
of  ||| S:1677 E:1680 ||| IN
the  ||| S:1680 E:1684 ||| DT
three  ||| S:1684 E:1690 ||| CD
genes  ||| S:1690 E:1696 ||| NNS
in  ||| S:1696 E:1699 ||| IN
the  ||| S:1699 E:1703 ||| DT
triple-knockout  ||| S:1703 E:1719 ||| JJ
mutant  ||| S:1719 E:1726 ||| NN
restored  ||| S:1726 E:1735 ||| VBD
the  ||| S:1735 E:1739 ||| DT
growth  ||| S:1739 E:1746 ||| NN
on  ||| S:1746 E:1749 ||| IN
glucose ||| S:1749 E:1756 ||| NN
.  ||| S:1756 E:1758 ||| .
These  ||| S:1758 E:1764 ||| DT
results  ||| S:1764 E:1772 ||| NNS
indicate  ||| S:1772 E:1781 ||| VBP
that  ||| S:1781 E:1786 ||| IN
C.  ||| S:1786 E:1789 ||| NNP
glutamicum  ||| S:1789 E:1800 ||| VBD
ATCC  ||| S:1800 E:1805 ||| NNP
31833  ||| S:1805 E:1811 ||| CD
has  ||| S:1811 E:1815 ||| VBZ
an  ||| S:1815 E:1818 ||| DT
additional  ||| S:1818 E:1829 ||| JJ
non-PTS  ||| S:1829 E:1837 ||| JJ
glucose  ||| S:1837 E:1845 ||| JJ
uptake  ||| S:1845 E:1852 ||| JJ
route  ||| S:1852 E:1858 ||| NN
consisting  ||| S:1858 E:1869 ||| VBG
of  ||| S:1869 E:1872 ||| IN
the  ||| S:1872 E:1876 ||| DT
bglF-specified  ||| S:1876 E:1891 ||| JJ
EII  ||| S:1891 E:1895 ||| NNP
permease  ||| S:1895 E:1904 ||| NN
and  ||| S:1904 E:1908 ||| CC
native  ||| S:1908 E:1915 ||| JJ
glucokinases ||| S:1915 E:1927 ||| NN
.  ||| S:1927 E:1929 ||| .
